Cover image of the article: Report of Two Brain Cancer Cases with Survey more than 15 Years

Image Credit:Int J Cancer Manag

Report of Two Brain Cancer Cases with Survey more than 15 Years

Authors

Habibollah Nemati Karimooy1,*, SA Tabatabaei Yazdi2, H Etemad Rezaei3, A Borzoei2, M Talebi dolooie4
1Dept. of Physiology and Neuroscience Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran
2Dept. of Pathology, Mashhad University of Medical Sciences, Mashhad, Iran
3Dept. of Neurosurgery, Mashhad University of Medical Sciences, Mashhad, Iran
4Dept. of Emergency Medicine, Imam Khomeini hospital, Tehran University of Medical Sciences, Tehran, Iran
*Corresponding Author: Corresponding author: Habibollah Nemati Karimooy, Dept. of Physiology and Neuroscience Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran, Tel: +98-5118002227, E-mail: Email: nematih@mums.ac.ir

International Journal of Cancer Management:Vol. 4, issue 2; e80737
Published online:Jun 30, 2011
Article type:Case Report
Received:Dec 02, 2009
Accepted:Sep 21, 2010
How to Cite:Nemati Karimooy H, Tabatabaei Yazdi S, Etemad Rezaei H, Borzoei A, Talebi dolooie M. Report of Two Brain Cancer Cases with Survey more than 15 Years. Int J Cancer Manag. 2011;4(2):e80737. doi:

Abstract

Brain tumors are considered in regarded to their size, position and aggressive manner. Brain tumors cause several neurologic symptoms. For instance, they increase intracranial pressure due to local damage and displacement of surrounding tissues. In this paper, two glioblastoma multiform cases with more than 15 year- survival have been reported. The first patient was a 52 year- old woman who suffered from seizure. The CT scan demonstrated a focal low density in the left temporoparietal lobe, and Carbamazepine was prescribed. However, after 12 years, the patient started to suffer from seizures with transient awareness repletion and vomiting. Therefore, daily injection of 16 mg of dexamethason in two divided dosages was prescribed. Fourteen years after illness, biopsy with stereotaxy method was used and glioblastoma multiform was diagnosed by a pathologist. Unfortunately, this patient died due to progression of her illness 16 years after beginning of the seizures. The second patient was a 47 year- old man who also suffered from seizure. In the CT scan, a low density lesion was observed in his left parietal lobe. The patient was treated with 400 mg of Carbamazepine per day in two divided dosages. Dosage of drug was increased to 1200 mg per day. After one year, due to drug resistance, Phenytoin and Phenobarbital were also added to Carbamazepine because of repeated seizures. After 15 years, the soberness disorder of the patient increased and CT scan was repeated. However, due to increase in the tumor size, hydrocephaly surgery was performed and the pathologist reported glioblastoma multiform. Following the surgery, radiotherapy and chemotherapy were also used. This patient is in a good condition now and he has no serious problems. Glioblastoma multiform is a high degree astrocytic tumor. In this paper, two patients who were afflicted with glioblastoma multiform in fourth and fifth decades of their life were presented. The life span of these patients is considerable in contrast to several articles which indicated that a- five -year life span is rare in patients with glioblastoma multiform.

Highlights

Fulltext

The Full text is available in PDF.

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

20
Mar
2017
Prognostic Factors and Survival of Glioblastoma Multiform (GBM) in Iranian Patients

Prognostic Factors and Survival of Glioblastoma Multiform (GBM) in Iranian Patients

Mojtaba Vand Rajabpour,
Hossein Yahyazadeh,
Marzie Beheshti

Vand Rajabpour M, Yahyazadeh H, Beheshti M. Prognostic Factors and Survival of Glioblastoma Multiform (GBM) in Iranian Patients. Int J Cancer Manag. 2017;10(4):e6260. doi: https://doi.org/10.5812/ijcm.6260

31
Dec
2017
Clinical Experience with Glioblastoma Multiforme in Pediatric Patients

Clinical Experience with Glioblastoma Multiforme in Pediatric Patients

Mahmoud Reza Khalatbari,
Yashar Moharamzad

Khalatbari MR, Moharamzad Y. Clinical Experience with Glioblastoma Multiforme in Pediatric Patients. Int J Cancer Manag. 2017;10(12):e8100. doi: https://doi.org/10.5812/ijcm.8100

20
Oct
2021
Cerebral Glioblastoma: A Review on Genetic Alterations, Signaling Pathways, and Clinical Managements

Cerebral Glioblastoma: A Review on Genetic Alterations, Signaling Pathways, and Clinical Managements

Nima Hasanzadeh,
Azadeh Niknejad

Hasanzadeh N, Niknejad A. Cerebral Glioblastoma: A Review on Genetic Alterations, Signaling Pathways, and Clinical Managements. Jentashapir J Cell Mol Biol. 2021;12(4):e119223. doi: https://doi.org/10.5812/jjcmb.119223

28
Nov
2022
Prognostic Factors for Survival of Patients with Glioblastoma in the Southern Region of Morocco

Prognostic Factors for Survival of Patients with Glioblastoma in the Southern Region of Morocco

Mohamed Amine Baba,
Mohamed lmejjati,
Nawal Adali

Baba MA, lmejjati M, Adali N. Prognostic Factors for Survival of Patients with Glioblastoma in the Southern Region of Morocco. Arch Neurosci. 2023;10(1):e132014. doi: https://doi.org/10.5812/ans-132014

30
Jun
2011
Mutational Analysis of the PTEN/MMAC1 Tumor Suppressor Gene in Sporadic Glioblastoma Multiforme

Mutational Analysis of the PTEN/MMAC1 Tumor Suppressor Gene in Sporadic Glioblastoma Multiforme

Najmeh Heshmatpour,
R Tavassoli,
P Mahzouni

Heshmatpour N, Tavassoli R, Mahzouni P. Mutational Analysis of the PTEN/MMAC1 Tumor Suppressor Gene in Sporadic Glioblastoma Multiforme. Int J Cancer Manag. 2011;4(2):e80730. doi:

More by these authors

Habibollah Nemati KarimooyPubMedScholar
SA Tabatabaei YazdiPubMedScholar
H Etemad RezaeiPubMedScholar
A BorzoeiPubMedScholar
M Talebi dolooiePubMedScholar
Share
Cited by
Metrics